Lyra Therapeutics
Latest round
- Series C
Last raised
- Jan 2020
Total raised
- $125M
Investors
- 10
About Lyra Therapeutics
Lyra Therapeutics, Inc.Founded in 2018, Lyra Therapeutics, Inc. operates as a biotechnology firm specializing in therapeutics for ear, nose, and throat disorders. The company is headquartered in Watertown, US. Maria Palasis is the CEO.50 mn in April 2022.Lyra Therapeutics, Inc. develops therapies aimed at treating various ENT conditions, leveraging advanced drug delivery technologies.In 2024, Lyra Therapeutics, Inc.Lyra Therapeutics, Inc. plans to expand its product offerings, focusing on additional therapies targeting chronic nasal conditions with anticipated launches in the near future. The company aims to penetrate new geographical markets, particularly in Europe and Asia, by 2025.
Who invested in Lyra Therapeutics
10 investors across 8 rounds
See all investors in Lyra Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jan 10, 2020
Amount
$30M
Investors
Series B
Sep 26, 2018
Amount
$30M
Investors
Series C
Apr 12, 2013
Amount
$18M
Investors
Series B
Sep 8, 2011
Amount
$12M
Investors
Series C
May 12, 2010
Amount
$10M
Investors
Series C
Apr 3, 2009
Amount
$12M
Investors
Series B
Nov 30, 2007
Amount
$0.1M
Investors
Series B
Sep 18, 2007
Amount
$13M
Investors
Questions about Lyra Therapeutics
Who invested in Lyra Therapeutics?
Lyra Therapeutics has 10 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lyra Therapeutics raised?
Lyra Therapeutics has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did Lyra Therapeutics last raise money?
Lyra Therapeutics's most recent round on record is a Series C, in Jan 2020.
What does Lyra Therapeutics do?
Lyra Therapeutics is a biotechnology company.
Where is Lyra Therapeutics headquartered?
Lyra Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Lyra Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lyra Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Lyra Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.